Skip to main navigation Skip to search Skip to main content

Gaucher disease in Colombia: Mutation identification and comparison to other hispanic populations

  • R. J. Pomponio
  • , M. A. Cabrera-Salazar
  • , O. Y. Echeverri
  • , G. Miller
  • , L. A. Barrera
  • Genzyme Corporation
  • Universidad Javeriana

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Gaucher disease is the most common of the lysosomal storage disorders, affecting all ethnic groups. The pathology of this recessively inherited disease arises from the accumulation of glucocerebroside in tissues due to deficient activity of the enzyme glucocerebrosidase (E.C. 3.2.1.45). The glucocerebrosidase (GBA) gene spans a 7.2 kb fragment located on locus 1q21, consisting of 11 exons and 10 introns. Located 16 kb downstream is a highly homologous pseudogene sequence [M. Horowitz, S. Wilder, Z. Horowitz, O. Reiner, T. Gelbart, E. Beutler, The Human Glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 4 (1) (1989) 87-96.]. Fourteen fragments comprising 11 exons of the GBA gene were analyzed in DNA samples from 25 Colombian patients using denaturing High Pressure Liquid Chromatography (DHPLC). Sequencing of abnormal findings led to the discovery of three novel mutations (c.595_596delCT, c.898delG and c.1255G > C [p.D419H] in exons 6, 7, and 9 of the GBA gene) with high prevalence among Colombian patients. We have also found the presence of a double mutation p.L483P + p.E355K (L444P + E326K, traditional nomenclature) in two different families classified as Gaucher type 1. This mutation was previously reported in one patient with Gaucher type 2. We have found DHPLC to be a reliable and sensitive method for the detection of mutations and allelic variation in Gaucher patients.

Original languageEnglish
Pages (from-to)466-472
Number of pages7
JournalMolecular Genetics and Metabolism
Volume86
Issue number4
DOIs
StatePublished - Dec 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Colombian patients
  • GBA
  • Gaucher disease
  • Glucocerebrosidase deficiency
  • Mutation

Fingerprint

Dive into the research topics of 'Gaucher disease in Colombia: Mutation identification and comparison to other hispanic populations'. Together they form a unique fingerprint.

Cite this